The untranslated region of μ-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice

Journal of Neuroscience

Volumn 21, Issue 4, 2001, Pages 1334-1339

  Ikeda, Kazutaka ^a,c   Kobayashi, Toru ^b   Ichikawa, Tomio ^b   Kumanishi, Toshiro ^b   Niki, Hiroaki ^a   Yano, Ryoji ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Analgesia; CXBK mouse; Individual difference; Morphine; UTR; opioid receptor

Indexed keywords

MU OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; FEMALE; LOCOMOTION; MALE; MOUSE; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0035866094     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-04-01334.2001     Document Type: Article

References (52)

1. Laser-stimulated luminescence used to measure x-ray diffraction of a contracting striated muscle
2. Recombinant inbred strains and bilineal congenic strains
3. Cumulative effect or independent effect?
4. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains
5. Mu opioid receptor gene variants: Lack of association with alcohol dependence
6. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains
7. Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse
8. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction
9. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
10. A method for determining loss of pain sensation
11. Diversity of cytoplasmic functions for the 3′ Untranslated region of eukaryotic transcripts
12. Are opioids effective in relieving neuropathic pain?
13. Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice
14. An unstable triplet repeat in a gene related to myotonic muscular dystrophy
15. Identification of the gene FMR2, associated with FRAXE mental retardation
16. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies
17. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island
18. Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel
19. + channel
20. + (GIRK) channels and functional couplings of the opioid receptors with the GIRK1 channel
21. + (GIRK) channel
22. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems
23. Unique behavioural phenotypes of recombinant-inbred CXBK mice: Partial deficiency of sensitivity to μ- and κ-agonists
24. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis
25. A gene for familial hemiplegic migraine maps to chromosome 19
26. Characterization of the murine mu opioid receptor gene
27. Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice
28. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene
29. Polymorphisms in the transcribed 3′ untranslated region of eukaryotic genes
30. Cloning and characterization of the promoter region of the mouse mu opioid receptor gene
31. mu Opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
32. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene
33. Strain differences in the magnitude of swimming-induced analgesia m mice correlate with brain opiate receptor concentration
34. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
35. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor
36. Opioid-like analgesia in defeated mice
37. The genetic mediation of individual differences in sensitivity to pain and its inhibition
38. Genetic sensitivity to hot-plate nociception in DBA/2J and C57BL/6J inbred mouse strains: Possible sex-specific mediation by delta2-opioid receptors
39. Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice
40. The gene for hereditary sensory neuropathy type I (HSN-I) maps to chromosome 9q22.1-q22.3
41. 2+ channel gene CACNL1A4
42. CXBK mice deficient in opiate receptors show poor electroacupuncture analgesia
43. Genetic basis of migraine
44. Calcium channel activation stabilizes a neuronal calcium channel mRNA
45. The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia
46. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia
47. Visceral chemical nociception in mice lacking mu-opioid receptors: Effects of morphine, SNC80 and U-50,488
48. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice
49. Post-transcriptional regulation of the GAP-43 gene by specific sequences in the 3′ untranslated region of the mRNA
50. The mu opiate receptor as a candidate gene for pain: Polymorphisms, variations in expression, nociception, and opiate responses
51. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
52. The evaluation of the analgesic action of pethidine hydrochloride (demerol)